rs201309183

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The NM_021098.3(CACNA1H):​c.4860C>T​(p.Asp1620Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,610,388 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 2 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

3

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.0460

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 16-1213862-C-T is Benign according to our data. Variant chr16-1213862-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 460129.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.046 with no splicing effect.
BS2
High AC in GnomAd4 at 32 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.4875C>T p.Asp1625Asp synonymous_variant Exon 26 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.4878C>T p.Asp1626Asp synonymous_variant Exon 26 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.4842C>T p.Asp1614Asp synonymous_variant Exon 26 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.4875C>T p.Asp1625Asp synonymous_variant Exon 27 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.4821C>T p.Asp1607Asp synonymous_variant Exon 27 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.4842C>T p.Asp1614Asp synonymous_variant Exon 26 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.4803C>T p.Asp1601Asp synonymous_variant Exon 26 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.4842C>T p.Asp1614Asp synonymous_variant Exon 26 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.4860C>T p.Asp1620Asp synonymous_variant Exon 27 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.4860C>T non_coding_transcript_exon_variant Exon 27 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.*812C>T non_coding_transcript_exon_variant Exon 26 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.4798C>T non_coding_transcript_exon_variant Exon 27 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*2711C>T non_coding_transcript_exon_variant Exon 27 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4304C>T non_coding_transcript_exon_variant Exon 25 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.4842C>T non_coding_transcript_exon_variant Exon 26 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.4842C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.4937C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.4860C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.4860C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.4842C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.4860C>T non_coding_transcript_exon_variant Exon 27 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.4860C>T non_coding_transcript_exon_variant Exon 27 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.4919C>T non_coding_transcript_exon_variant Exon 26 of 35 ENSP00000518777.1
CACNA1HENST00000637236.3 linkn.*812C>T 3_prime_UTR_variant Exon 26 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000640028.1 linkn.*2711C>T 3_prime_UTR_variant Exon 27 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*4304C>T 3_prime_UTR_variant Exon 25 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000268
AC:
65
AN:
242918
AF XY:
0.000235
show subpopulations
Gnomad AFR exome
AF:
0.000137
Gnomad AMR exome
AF:
0.0000294
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.000564
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000382
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.000230
AC:
335
AN:
1458102
Hom.:
2
Cov.:
31
AF XY:
0.000233
AC XY:
169
AN XY:
724968
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33438
American (AMR)
AF:
0.000226
AC:
10
AN:
44340
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26050
East Asian (EAS)
AF:
0.000152
AC:
6
AN:
39596
South Asian (SAS)
AF:
0.000281
AC:
24
AN:
85444
European-Finnish (FIN)
AF:
0.0000572
AC:
3
AN:
52470
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000245
AC:
272
AN:
1110732
Other (OTH)
AF:
0.000265
AC:
16
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152286
Hom.:
0
Cov.:
33
AF XY:
0.000242
AC XY:
18
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41586
American (AMR)
AF:
0.000261
AC:
4
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000323
AC:
22
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000379
Hom.:
0
Bravo
AF:
0.000166

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

CACNA1H-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.24
DANN
Benign
0.68
PhyloP100
0.046
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201309183; hg19: chr16-1263862; API